Myasthenic crisis in the setting of Coronavirus Disease 2019 (COVID-19) - 18/11/20
Doi : 10.1016/j.jclinane.2020.110001
Irim Salik, MD ⁎ 
, Heather Brosnan Rodhouse, MD, Samuel Barst, MD
, Heather Brosnan Rodhouse, MD, Samuel Barst, MD Department of Anesthesiology at Westchester Medical Center, New York Medical College, Valhalla, NY, United States of America
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | A patient with Myasthenia Gravis (MG) on immunosuppressive therapy with underlying respiratory compromise may be more susceptible to infection with COVID-19 or severe manifestations of the virus. |
• | It is theorized that patients with MG may be more vulnerable to bacterial and viral infections, due to respiratory muscle weakness and use of immunosuppressive medications. |
• | It is critical for practitioners to be prepared for severe respiratory compromise in patients with MG and concomitant COVID-19 superinfection. |
• | In light of the COVID-19 pandemic, MG patients should be encouraged to continue their current treatment regimens, but engage in extra vigilant social distancing. |
© 2020
Publié par Elsevier Masson SAS.
Vol 67
Article 110001- décembre 2020 Retour au numéro
Article précédent
- Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia
- Sandeep Krishnan, Kinjal Patel, Ronak Desai, Anupam Sule, Peter Paik, Ashley Miller, Alicia Barclay, Adam Cassella, Jon Lucaj, Yvonne Royster, Joffer Hakim, Zulfiqar Ahmed, Farhad Ghoddoussi
- Acquired infection after intubating patients with COVID-19: A retrospective pilot study
- Jiaqiang Zhang, Mingyang Sun, Ningtao Li, Xiaoyan Suo, Zhongyuan Xia, Mingzhang Zuo, Renyu Liu
Bienvenue sur EM-consulte, la référence des professionnels de santé.